Clinical Immunology, Neuropharmacology and Drug Development

Next-Generation Immunotherapies in Neurological Disorders

This track invites abstracts that explore cutting-edge immunotherapeutic strategies for treating neurological disorders. Researchers are encouraged to submit work on novel biologics, cell-based therapies, and other innovative approaches that modulate the immune system to target conditions such as multiple sclerosis, Alzheimer’s disease, and autoimmune encephalitis. Attendees can expect to gain insights into the latest advancements in immunotherapy, including preclinical studies, clinical trials, and the development of next-generation drugs. The track will also cover the challenges of translating these therapies into clinical practice, including safety, efficacy, and personalized treatment approaches.